Michaela Ann Dinan | Scholars@Duke

Michaela Ann Dinan
Assistant Professor in Population Health Sciences

Dr. Dinan is a health services researcher with a focus on emerging medical technology in cancer. Dr. Dinan currently holds an AHRQ K99/R00 pathway to independence award to examine adoption of Oncotype DX molecular testing in breast cancer and has conducted work in breast and other cancers examining emerging technologies and their associated disparities in utilization, outcomes and costs. Dr. Dinan has expertise in both secondary data analysis and clinical registry methodologies. Her secondary data expertise include the SEER-Medicare linked data, Medicare claims, NIS, NCDB, as well as EHR data.

Dr. Dinan holds additional appointments at the Duke Clinical Research Institute and Duke Cancer Institute where she co-leads the Patient Experience and Survivorship Focus Area in the Cancer Control and Population Sciences Program.

Areas of expertise: Health Economics, Health Policy, and Health Services Research

Current Appointments & Affiliations

Assistant Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2017
Assistant Professor in Medicine, Medicine, Medical Oncology, Medicine 2018
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2013
Membership in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2013

Contact Information

2200 West Main Street Suite 720-A, Durham, NC 27705
Duke Box 104023, Durham, NC 27710
michaela.dinan@duke.edu (919) 668-8177

Background
Education, Training, & Certifications
- Ph.D., University of North Carolina at Chapel Hill 2011
- B.S., University of Virginia 2003
Duke Appointment History
- Assistant Professor in Medicine, Medicine, Medical Oncology, Medicine 2015 - 2017
- Medical Instructor in the Department of Medicine, Medicine, Medical Oncology, Medicine 2013 - 2015
Recognition
In the News
- AUG 27, 2015
  
  Breast Cancer Risk Score Impacts Use of Chemotherapy
Expertise
Subject Headings
- Health Services
- Population Health
Global Scholarship
- Research
  - United States of America (Country)
Research
Selected Grants
- National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer awarded by Agency for Healthcare Research and Quality 2015 - 2018
- Bladder Cancer in Older Adults - Treatment and Outcomes awarded by AstraZeneca Pharmaceuticals, LP 2016 - 2017
- Thyrogen Utilization Patterns in the Treatment of Thyroid Cancer awarded by Genzyme Corporation 2015 - 2017
- National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer awarded by Agency for Healthcare Research and Quality 2013 - 2015
- Cardiac Imaging awarded by BC Cancer Research Centre 2014 - 2015
Publications & Artistic Works
Selected Publications
- Conference Papers
  - Robinson, TJ, Dinan, MA, Li, Y, Lee, WR, and Reed, SD. "Longitudinal Trends in Costs for Palliative Radiation for Metastatic Prostate Cancer." October 1, 2013. Full Text Link to Item
- Journal Articles
  - Clough, JD, Dinan, MA, and Schulman, KA. "Trends in hospital-physician integration in medical oncology." The American journal of managed care 23, no. 10 (October 2017): 624-627.
  - Harowicz, MR, Robinson, TJ, Dinan, MA, Saha, A, Marks, JR, Marcom, PK, and Mazurowski, MA. "Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset." Breast cancer research and treatment 162, no. 1 (February 2017): 1-10. Full Text
  - Kim, E, Dinan, M, Islam, KM, Fernandes, A, Schwartzberg, L, Croft, E, Brahmer, J, Mansfield, A, Hyslop, T, Burke, L, and Crawford, J. "PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11, no. 11S (November 2016): S308-S309. Full Text
  - Robinson, TJ, Thomas, S, Dinan, MA, Roman, S, Sosa, JA, and Hyslop, T. "How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 28 (October 2016): 3434-3439. Full Text
  - Ruel, E, Thomas, S, Dinan, MA, Perkins, JM, Roman, SA, and Sosa, JA. "Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer." Endocrine 52, no. 3 (June 2016): 579-586. Full Text
  - Roberts, MC, Bryson, A, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, KE, and Wheeler, SB. "Patient-Centered Communication for Discussing Oncotype DX Testing." Cancer investigation 34, no. 5 (May 2016): 205-212. Full Text
  - Cohen, SM, Dinan, MA, Kim, J, and Roy, N. "Otolaryngology utilization of speech-language pathology services for voice disorders." The Laryngoscope 126, no. 4 (April 2016): 906-912. Full Text
  - Dinan, MA, Li, Y, Zhang, Y, Stewart, SB, Curtis, LH, George, DJ, and Reed, SD. "Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer." Clinical genitourinary cancer 14, no. 1 (February 2016): 28-37.e2. Full Text
  - Roberts, MC, Bryson, A, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, K, and Wheeler, SB. "ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY." International journal of technology assessment in health care 32, no. 5 (January 2016): 355-361. Full Text
  - Roberts, MC, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, KE, Carey, LA, Troester, MA, and Wheeler, SB. "Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 2 (January 2016): 130-138. Full Text
  - Dinan, MA, Mi, X, Reed, SD, Lyman, GH, and Curtis, LH. "Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009." JAMA oncology 1, no. 8 (November 2015): 1098-1109. Full Text
  - Adam, MA, Choudhury, K, Dinan, MA, Reed, SD, Scheri, RP, Blazer, DG, Roman, SA, and Sosa, JA. "Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients." Annals of surgery 262, no. 2 (August 2015): 372-377. Full Text
  - Roberts, MC, Weinberger, M, Dusetzina, SB, Dinan, MA, Reeder-Hayes, KE, Troester, MA, Carey, LA, and Wheeler, SB. "Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing." Breast cancer research and treatment 153, no. 1 (August 2015): 191-200. Full Text
  - Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Reed, SD, Scheri, RP, Hyslop, T, Roman, SA, and Sosa, JA. "Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33, no. 21 (July 2015): 2370-2375. Full Text
  - Dinan, MA, Mi, X, Reed, SD, Hirsch, BR, Lyman, GH, and Curtis, LH. "Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009." JAMA oncology 1, no. 2 (May 2015): 158-166. Full Text
  - Havrilesky, LJ, Dinan, M, Sfakianos, GP, Curtis, LH, Barnett, JC, Van Gorp, T, and Myers, ER. "Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass." Obstetrical & Gynecological Survey 70, no. 4 (April 2015): 253-255. Full Text
  - Ruel, E, Thomas, S, Dinan, M, Perkins, JM, Roman, SA, and Sosa, JA. "Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer." The Journal of clinical endocrinology and metabolism 100, no. 4 (April 2015): 1529-1536. Full Text
  - Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years." The Journal of clinical endocrinology and metabolism 100, no. 1 (January 2015): 115-121. Full Text
  - Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years." Journal of Clinical Endocrinology and Metabolism 100, no. 1 (2015): 115-121. Full Text
  - Dinan, MA, Hirsch, BR, and Lyman, GH. "Management of chemotherapy-induced neutropenia: measuring quality, cost, and value." Journal of the National Comprehensive Cancer Network : JNCCN 13, no. 1 (January 2015): e1-e7. (Review) Full Text
  - Havrilesky, LJ, Dinan, M, Sfakianos, GP, Curtis, LH, Barnett, JC, Van Gorp, T, and Myers, ER. "Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass." JNCI Journal of the National Cancer Institute 107, no. 1 (January 2015): 322-. Full Text
  - Dinan, MA, and Schulman, KA. "Exploring variation in care: alternative conceptual models." Annals of internal medicine 161, no. 11 (December 2014): 835-836. Full Text
  - Adam, MA, Speicher, P, Pura, J, Dinan, MA, Reed, SD, Roman, SA, and Sosa, JA. "Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes." Annals of surgical oncology 21, no. 12 (November 2014): 3859-3864. Full Text
  - Adam, MA, Pura, J, Gu, L, Dinan, MA, Tyler, DS, Reed, SD, Scheri, R, Roman, SA, and Sosa, JA. "Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients." Annals of surgery 260, no. 4 (October 2014): 601-605. Full Text
  - Gratian, L, Pura, J, Dinan, M, Reed, S, Scheri, R, Roman, S, and Sosa, JA. "Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States." Annals of surgical oncology 21, no. 11 (October 2014): 3509-3514. Full Text
  - Gratian, L, Pura, J, Dinan, M, Roman, S, Reed, S, and Sosa, JA. "Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States." Annals of surgical oncology 21, no. 11 (October 2014): 3515-3521. Full Text
  - Dinan, MA, Curtis, LH, Carpenter, WR, Biddle, AK, Abernethy, AP, Patz, EF, Schulman, KA, and Weinberger, M. "Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 9, no. 4 (April 2014): 512-518. Full Text
  - Abdelgadir Adam, M, Speicher, P, Pura, J, Dinan, MA, Reed, SD, Roman, SA, and Sosa, JA. "Robotic Thyroidectomy for Cancer in the US: Patterns of Use and Short-Term Outcomes." Annals of Surgical Oncology 21, no. 12 (January 1, 2014): 3859-3864. Full Text
  - Cohen, SM, Dinan, MA, Roy, N, Kim, J, and Courey, M. "Diagnosis change in voice-disordered patients evaluated by primary care and/or otolaryngology: a longitudinal study." Otolaryngol Head Neck Surg 150, no. 1 (January 2014): 95-102. Full Text Link to Item
  - Gratian, L, Pura, J, Dinan, M, Reed, S, Scheri, R, Roman, S, and Sosa, JAN. "Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States." Annals of surgical oncology 21, no. 11 (2014): 3509-3514. Full Text
  - Gratian, L, Pura, J, Dinan, M, Roman, S, Reed, S, and Sosa, JAN. "Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States." Annals of surgical oncology 21, no. 11 (2014): 3515-3521. Full Text
  - Moorman, PG, Havrilesky, LJ, Gierisch, JM, Coeytaux, RR, Lowery, WJ, Peragallo Urrutia, R, Dinan, M, McBroom, AJ, Hasselblad, V, Sanders, GD, and Myers, ER. "Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis." J Clin Oncol 31, no. 33 (November 20, 2013): 4188-4198. (Review) Full Text Link to Item
  - Gierisch, JM, Coeytaux, RR, Urrutia, RP, Havrilesky, LJ, Moorman, PG, Lowery, WJ, Dinan, M, McBroom, AJ, Hasselblad, V, Sanders, GD, and Myers, ER. "Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review." Cancer Epidemiol Biomarkers Prev 22, no. 11 (November 2013): 1931-1943. (Review) Full Text Link to Item
  - Peragallo Urrutia, R, Coeytaux, RR, McBroom, AJ, Gierisch, JM, Havrilesky, LJ, Moorman, PG, Lowery, WJ, Dinan, M, Hasselblad, V, Sanders, GD, and Myers, ER. "Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis." Obstetrics and gynecology 122, no. 2 Pt 1 (August 1, 2013): 380-389. (Review)
  - Peragallo Urrutia, R, Coeytaux, RR, McBroom, AJ, Gierisch, JM, Havrilesky, LJ, Moorman, PG, Lowery, WJ, Dinan, M, Hasselblad, V, Sanders, GD, and Myers, ER. "Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis." Obstet Gynecol 122, no. 2 Pt 1 (August 2013): 380-389. (Review) Full Text Link to Item
  - Havrilesky, LJ, Moorman, PG, Lowery, WJ, Gierisch, JM, Coeytaux, RR, Urrutia, RP, Dinan, M, McBroom, AJ, Hasselblad, V, Sanders, GD, and Myers, ER. "Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis." Obstet Gynecol 122, no. 1 (July 2013): 139-147. (Review) Full Text Link to Item
  - Dinan, MA, Curtis, LH, Carpenter, WR, Biddle, AK, Abernethy, AP, Patz, EF, Schulman, KA, and Weinberger, M. "Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007." Radiology 267, no. 3 (June 2013): 807-817. Full Text Link to Item
  - Havrilesky, LJ, Gierisch, JM, Moorman, PG, Coeytaux, RR, Urrutia, RP, Lowery, WJ, Dinan, M, McBroom, AJ, Wing, L, Musty, MD, Lallinger, KR, Hasselblad, V, Sanders, GD, and Myers, ER. "Oral contraceptive use for the primary prevention of ovarian cancer." Evidence report/technology assessment , no. 212 (June 2013): 1-514. (Review)
  - Reed, SD, Dinan, MA, Schulman, KA, and Lyman, GH. "Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer." Genet Med 15, no. 3 (March 2013): 203-211. Full Text Link to Item
  - Dinan, MA, Carpenter, WR, Patz, EF, Abernethy, AP, Biddle, AK, Schulman, KA, and Curtis, LH. "Reply to M.S. Hofman et al." J Clin Oncol 31, no. 6 (February 20, 2013): 820-. (Letter) Full Text Link to Item
  - Havrilesky, LJ, Moorman, PG, Lowery, WJ, Gierisch, JM, Coeytaux, RR, Urrutia, RP, Dinan, M, McBroom, AJ, Hasselblad, V, Sanders, GD, and Myers, ER. "Oral contraceptive pills as primary prevention for ovarian cancer: A systematic review and meta-analysis." Obstetrics and Gynecology 122, no. 1 (2013): 139-147. Full Text
  - Dinan, MA, Curtis, LH, Carpenter, WR, Biddle, AK, Abernethy, AP, Patz, EF, Schulman, KA, and Weinberger, M. "Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003." J Clin Oncol 30, no. 22 (August 1, 2012): 2725-2730. Full Text Link to Item
  - Dinan, MA, Robinson, TJ, Zagar, TM, Scales, CD, Curtis, LH, Reed, SD, Lee, WR, and Schulman, KA. "Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007." Int J Radiat Oncol Biol Phys 82, no. 5 (April 1, 2012): e781-e786. Full Text Link to Item
  - Dewitt, EM, Grussemeyer, CA, Friedman, JY, Dinan, MA, Lin, L, Schulman, KA, and Reed, SD. "Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial." Value Health 15, no. 2 (March 2012): 277-283. Full Text Link to Item
  - Dinan, MA, Robinson, TJ, Zagar, TM, Scales, CD, Curtis, LH, Reed, SD, Schulman, KA, and Lee, WR. "Financial implications of changes in the initial treatment of prostate cancer among Medicare beneficiaries." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): 6115-.
  - Dinan, MA, Compton, KL, Dhillon, JK, Hammill, BG, Dewitt, EM, Weinfurt, KP, and Schulman, KA. "Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials." Med Care 49, no. 4 (April 2011): 415-419. (Review) Full Text Link to Item
  - Dinan, MA, Chou, C-H, Hammill, BG, Graham, FL, Schulman, KA, Telen, MJ, and Reed, SD. "Erratum: Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures." American Journal of Hematology 86, no. 10 (2011): 906-908. Full Text
  - Dinan, MA, Compton, KL, Dhillon, JK, Hammill, BG, DeWitt, EM, Weinfurt, KP, and Schulman, KA. "Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials." Medical Care 49, no. 4 (January 1, 2011): 415-419. Full Text
  - Dinan, MA, Compton, KL, Dhillon, JK, Hammill, BG, Witt, EMD, Weinfurt, KP, and Schulman, KA. "Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials." Medical Care (2011). Full Text
  - Kamble, S, Telen, MJ, Dinan, MA, Grussemeyer, CA, and Reed, SD. "Erratum: Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement." American Journal of Hematology 86, no. 10 (2011): 903--. Full Text
  - Dinan, MA, Simmons, LA, and Snyderman, R. "Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: an opportunity for academic medicine to lead health care reform." Acad Med 85, no. 11 (November 2010): 1665-1668. Full Text Link to Item
  - Dinan, MA, Curtis, LH, Hammill, BG, Patz, EF, Abernethy, AP, Shea, AM, and Schulman, KA. "Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006." JAMA 303, no. 16 (April 28, 2010): 1625-1631. Full Text Link to Item
  - Robinson, TJ, Dinan, MA, Dewhirst, M, Garcia-Blanco, MA, and Pearson, JL. "SplicerAV: a tool for mining microarray expression data for changes in RNA processing. (Published online)" BMC Bioinformatics 11 (February 25, 2010): 108-. Full Text Open Access Copy Link to Item
  - Snyderman, R, and Dinan, MA. "Improving health by taking it personally." JAMA 303, no. 4 (January 27, 2010): 363-364. Full Text Link to Item
  - Kamble, S, Telen, MJ, Dinan, MA, Grussemeyer, CA, and Reed, SD. "Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement." Am J Hematol 85, no. 1 (January 2010): 79-81. (Letter) Full Text Link to Item
  - Dinan, MA, Chou, C-H, Hammill, BG, Graham, FL, Schulman, KA, Telen, MJ, and Reed, SD. "Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures." Am J Hematol 84, no. 11 (November 2009): 703-709. Full Text Link to Item
  - Weinfurt, KP, Hall, MA, Dinan, MA, DePuy, V, Friedman, JY, Allsbrook, JS, and Sugarman, J. "Effects of disclosing financial interests on attitudes toward clinical research." J Gen Intern Med 23, no. 6 (June 2008): 860-866. Full Text Link to Item
  - Friedman, JY, Sugarman, J, Dhillon, JK, Depuy, V, Pierre, CK, Dinan, MA, Allsbrook, JS, Schulman, KA, and Weinfurt, KP. "Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants." Clin Trials 4, no. 3 (2007): 272-278. Full Text Link to Item
  - Weinfurt, KP, Allsbrook, JS, Friedman, JY, Dinan, MA, Hall, MA, Schulman, KA, and Sugarman, J. "Developing model language for disclosing financial interests to potential clinical research participants." IRB 29, no. 1 (January 2007): 1-5. Link to Item
  - Dinan, MA, Weinfurt, KP, Friedman, JY, Allsbrook, JS, Gottlieb, J, Schulman, KA, Hall, MA, Dhillon, JK, and Sugarman, J. "Comparison of conflict of interest policies and reported practices in academic medical centers in the United States." Account Res 13, no. 4 (October 2006): 325-342. Full Text Link to Item
  - Weinfurt, KP, Friedman, JY, Allsbrook, JS, Dinan, MA, Hall, MA, and Sugarman, J. "Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure." J Gen Intern Med 21, no. 9 (September 2006): 901-906. Full Text Link to Item
  - Weinfurt, KP, Dinan, MA, Allsbrook, JS, Friedman, JY, Hall, MA, Schulman, KA, and Sugarman, J. "Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants." Acad Med 81, no. 2 (February 2006): 113-118. Link to Item
  - Weinfurt, KP, Friedman, JY, Dinan, MA, Allsbrook, JS, Hall, MA, Dhillon, JK, and Sugarman, J. "Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators." J Law Med Ethics 34, no. 3 (2006): 581-481. Link to Item
- Other Articles
  - Goffredo, P, Thomas, SM, Dinan, MA, Perkins, JM, Roman, SA, and Sosa, JA. "Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse." JAMA internal medicine 175, no. 4 (April 2015): 638-640. Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Subject Headings

Global Scholarship

Research

Selected Grants

Selected Publications

Conference Papers

Journal Articles

Other Articles